Keyphrases
Cystic Fibrosis
100%
Estrogen Supplementation
31%
Vitamin D
22%
Estrogen
22%
Low Bone Mineral Density
19%
Cystic Fibrosis Lung Infection
19%
Bone Mineral Density
15%
Single Center
15%
Short Stature
14%
High-dose Vitamin D
14%
Bone Turnover
14%
Osteogenesis Imperfecta
14%
Skeletal Mineralization
14%
Tissue-nonspecific Alkaline Phosphatase
14%
Acute Pulmonary Exacerbation
14%
Hispanic Females
14%
Quality of Life Assessment
14%
Skeletal Fractures
14%
High Quality of Life
14%
Vitamin D Supplementation
14%
GPI-anchored Protein (GPI-AP)
14%
Access to Care
14%
COVID-19 Pandemic
14%
Ethinylestradiol
14%
Asfotase Alfa
14%
Estrogen Treatment
14%
Hypogonadal Men
14%
Fracture Healing
14%
Cystic Fibrosis-related Diabetes
14%
Skeletal Health
14%
Estradiol
14%
Estradiol Treatment
14%
Variant Impact
14%
Racial Disparities
14%
Cystic Fibrosis Diagnosis
14%
CF Transmembrane Conductance Regulator
14%
Inorganic Phosphate
10%
Quality of Life
9%
Bone Turnover Markers
9%
Growth Velocity
8%
Placebo
7%
Multiple Congenital Anomalies
7%
Hypotonia
7%
Inorganic Pyrophosphate
7%
Skeletal Fragility
7%
Pathogenic Variants
7%
Metabolic Bone Disease
7%
Seizure
7%
Estrogen Replacement Therapy
6%
Bone Disease
6%
Medicine and Dentistry
Cystic Fibrosis
84%
Supplementation
29%
Bone Disease
18%
Quality of Life
17%
Vitamin D
16%
Bone Turnover
15%
Osteogenesis Imperfecta
14%
Diethylstilbestrol
14%
Diabetes
14%
Cohort Analysis
14%
Short Stature
14%
Asfotase Alfa
14%
Drug Megadose
14%
COVID-19
14%
Cystic Fibrosis Transmembrane Conductance Regulator
14%
Bone Density
10%
Placebo
9%
Growth Rate
8%
Estrogen Therapy
8%
Telehealth
6%
Medical Care
6%
Disease
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
70%
Bone Disease
19%
Vitamin D
16%
Glucocorticoid
15%
Cohort Study
15%
Growth Hormone
14%
Muscular Dystrophy
14%
Diethylstilbestrol
14%
Asfotase Alfa
14%
Ethinylestradiol
14%
Spine Fracture
14%
Zoledronic Acid
12%
Placebo
9%